FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from peer-reviewed literature for educational reference.
Neuropeptide

Selank + Semax

  • Selank/Semax Blend
  • Nootropic Blend

A co-formulated lyophilized blend of two Russian-research heptapeptides — Selank (anxiolytic) and Semax (nootropic) — for paired neuropeptide research models.

Selank + Semax
CoA available on request
  • Free shipment protection
  • Free shipping on $250+
  • Damage protection
  • 256-bit SSL checkout

Dual neuropeptide

Selank anxiolytic + Semax nootropic profiles.

BDNF + GABA research

Studied in CNS and stress-response models.

99%+ identity purity

HPLC + MS verified per batch. CoA included.

MOLECULAR PROFILE

What Is Selank + Semax?

A two-peptide blend pairing Selank with Semax in a single vial. Both are heptapeptide neuropeptides with distinct but complementary research profiles — Selank with anxiolytic and immunomodulatory activity, Semax with nootropic and neuroprotective activity — used together in preclinical CNS studies.

COMPOUND INFORMATION

Technical specifications

Type
Two-peptide research blend
Appearance
White lyophilized powder
Identity purity
≥ 99% (HPLC + MS) per component
SOURCES & REFERENCES

Peer-reviewed research

  1. Acta Naturae
    Anxiolytic peptide drug selank: clinical applications and prospects
    2018
    Medvedev VE, Tereshchenko OV, Kost NV et al.
  2. Brain Res
    Semax peptide alleviates adverse effects of cerebral hypoxia in rats
    2008· PMID: 18558459View on PubMed →
    Stavchansky VV, Yuzhakov VV, Botsina AYu et al.
View all related research on PubMed
RELATED RESEARCH

Frequently researched together

IMPORTANT RESEARCH NOTICE

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.